NLRP3 and hematopoietic and lymphoid system neoplasm: Specifically, overexpression of NLRP3 in some types of blood cancers, including ALL and acute myeloid leukemia (AML), is associated with poor prognosis (reviewed in Urwanisch et al.17, 18).